text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 105355-26-8 | Product Number: A2567


Purity: >98.0%(T)(HPLC)
  • 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2-imino-4-thiazolidinone
Contact Us 2   7  
Contact Us 1   7  

*Upon orders receipt, Hyderabad stocks will be dispatched on the same day & Chennai stocks will be dispatched in 3-6 working days.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*Change currency to place order in USD.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Product Number A2567
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__9H__2__1N__3O__2S = 355.46  
Physical State (20 deg.C) Solid
CAS RN 105355-26-8
Reaxys Registry Number 3564388
PubChem Substance ID 172089159
MDL Number


Appearance White to Light yellow to Light orange powder to crystalline
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 194.0 to 198.0 °C
Properties (reference)
Melting Point 196 °C
Related Laws:
Transport Information:
A Key Synthetic Intermediate of Pioglitazone Hydrochloride

This product is a key synthetic intermediate of pioglitazone hydrochloride [P1901] which is an agonist at the peroxisome proliferator-activated receptor of the gamma subtype (PPARγ), a transcription-regulating receptor. (The product is for research purpose only.)


PubMed Literature

Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents